EBOO (Extracorporeal Blood Oxygenation and Ozonation) is a clinical procedure in which a portion of your blood is drawn into a closed external circuit, passed through medical-grade filtration, exposed to controlled concentrations of oxygen and ozone, and returned to your body in real time. At Forbidden Well in New York City, EBOO is administered as a structured, consultation-based program for patients pursuing advanced circulatory support and systemic performance optimization.

Most healthy adults are eligible for EBOO therapy. Eligibility is determined through a clinical consultation that reviews your health history, current medications, immune status, lifestyle factors, and treatment goals. Because EBOO requires steady extracorporeal blood flow, adequate venous access is essential. Patients with small, fragile, or difficult-to-access veins may not be candidates. Those with certain medical conditions may require additional clearance before beginning treatment.

EBOO therapy is not the same as traditional ozone therapy, though it incorporates medical ozone as one component of a broader extracorporeal process. Standard ozone therapies typically involve small-volume blood exposure or localized application. EBOO circulates a significantly larger volume of blood through a closed medical system, combining oxygenation, precisely calibrated ozonation, and filtration under continuous clinical monitoring. This makes it a more comprehensive and systemically oriented intervention than conventional ozone techniques.

EBOO shares a mechanical similarity with dialysis in that both use extracorporeal circulation, but the purpose and outcome are different. Dialysis replaces kidney function and corrects fluid and solute imbalances. EBOO does not remove electrolytes or exchange blood volume. Instead, it circulates blood through a dual-line closed system, one line drawing blood out and one returning it, for the purpose of oxygenation, filtration, and controlled ozone exposure. The goal is optimized blood quality, not fluid correction.

A standard EBOO session processes approximately 2 liters of blood. Given that the average adult has roughly 5 liters of total blood volume, this represents a meaningful portion of systemic circulation. This volume allows the procedure to influence oxygenation, support metabolic clearance, and affect circulatory function at a level that smaller-volume ozone treatments cannot reach. The active treatment runs approximately 50 minutes within a 90-minute appointment.

Every EBOO session at Forbidden Well begins with a comprehensive intake review, consent documentation, vital sign assessment, and pre-procedure evaluation. Throughout the session, clinical staff monitor vital signs, blood glucose, oxygenation, and circulation in real time. The extracorporeal system includes multiple built-in safety controls and operates under standardized clinical protocols. Glucose support is kept on hand throughout every session as a standard safety measure. All treatments are supervised from start to finish by trained clinical professionals.

A full EBOO appointment at Forbidden Well is scheduled for 90 minutes. The active treatment runs approximately 50 minutes, with the remaining time allocated for venous assessment, dual-arm setup, patient preparation, and post-treatment monitoring. This structure ensures the procedure is never rushed and that every patient is properly evaluated before, during, and after blood circulation begins.

Clinical experience and available research on extracorporeal ozone therapy suggest that a series of sessions produces more consistent and measurable results than a single treatment. At Forbidden Well, we strongly recommend a minimum of 4 sessions spaced one week apart. This spacing allows the circulatory and oxidative effects to build progressively and gives the body adequate time to respond between treatments. After an initial series, many patients maintain results with sessions every 4 to 8 weeks based on their physiology and goals.

Research on extracorporeal ozone-based therapies consistently shows that cumulative sessions produce stronger physiologic outcomes than single treatments. A series of four allows oxidative balance to stabilize, circulatory adaptation to occur, and systemic changes in energy, inflammation, and metabolic performance to become measurable. Single sessions provide support, but the compounding effect of a structured program is where clinically meaningful results are most reliably achieved. We recommend four sessions as the starting point based on this evidence and our clinical experience with the protocol.

Most patients describe EBOO as calm and uneventful. Once the two IV lines are placed, you remain reclined while blood circulates through the system. Some patients notice a mild sense of warmth or lightness. Others feel nothing at all. Because the process is slow and precisely controlled, it does not feel like a rapid blood exchange. Vitals are monitored continuously throughout, and glucose support is available as a standard precaution to maintain blood sugar stability during treatment.